相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunological Properties of Neural Crest Cells Derived from Human Induced Pluripotent Stem Cells
Shota Fujii et al.
STEM CELLS AND DEVELOPMENT (2019)
Enhanced Antitumor Efficacy of Oncolytic Adenovirus-loaded Menstrual Blood-derived Mesenchymal Stem Cells in Combination with Peripheral Blood Mononuclear Cells
Rafael Moreno et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines
Stephen J. Russell et al.
CANCER CELL (2018)
Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer
Kazuho Inoko et al.
CANCER GENE THERAPY (2018)
Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer
Giulia Marelli et al.
FRONTIERS IN IMMUNOLOGY (2018)
A Retroviral Replicating Vector Encoding Cytosine Deaminase and 5-FC Induces Immune Memory in Metastatic Colorectal Cancer Models
Kader Yagiz et al.
MOLECULAR THERAPY-ONCOLYTICS (2018)
Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy
Carole Achard et al.
EBIOMEDICINE (2018)
Tumor-Associated Macrophages as Target for Antitumor Therapy
Katarzyna Sawa-Wejksza et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2018)
The Efficacy of Oncolytic Adenovirus Is Mediated by T-cell Responses against Virus and Tumor in Syrian Hamster Model
Xiaozhu Li et al.
CLINICAL CANCER RESEARCH (2017)
Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy
E. Ilett et al.
GENE THERAPY (2017)
Designing and building oncolytic viruses
Justin Maroun et al.
FUTURE VIROLOGY (2017)
Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus
Nusrat Jahan et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Michael J. Overman et al.
LANCET ONCOLOGY (2017)
Retroviral replicating vector-mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity
Kei Hiraoka et al.
NEURO-ONCOLOGY (2017)
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
J. Weber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas
Wanlu Du et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Tumor-homing cytotoxic human induced neural stem cells for cancer therapy
Juli R. Bago et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Mesenchymal stem cells for treating autoimmune dacryoadenitis
Xiaoxiao Lu et al.
STEM CELL RESEARCH & THERAPY (2017)
Oncolytic immunotherapy: Conceptual evolution, Current Strategies, and Future Perspectives
Zong Sheng Guo et al.
FRONTIERS IN IMMUNOLOGY (2017)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas et al.
CELL (2017)
The combination of NK and CD8+T cells with CCL20/IL15-armed oncolytic adenoviruses enhances the growth suppression of TERT-positive tumor cells
Jun-Feng Ye et al.
CELLULAR IMMUNOLOGY (2017)
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
Dipongkor Saha et al.
CANCER CELL (2017)
Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer
Kyung Hee Jung et al.
CANCER LETTERS (2017)
Oncolytic Adenoviral Delivery of an EGFR-Targeting T-cell Engager Improves Antitumor Efficacy
Carlos Alberto Fajardo et al.
CANCER RESEARCH (2017)
A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now
Joaquin Bellmunt et al.
CANCER TREATMENT REVIEWS (2017)
The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma
Naiara Martinez-Velez et al.
CLINICAL CANCER RESEARCH (2016)
Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy
Li Ran et al.
BIOMATERIALS (2016)
Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma
Robert H. I. Andtbacka et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Interview with Robert Coffin, inventor of T-VEC: the first oncolytic immunotherapy approved for the treatment of cancer
Ellen Clarke et al.
IMMUNOTHERAPY (2016)
Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
Igor Puzanov et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
Karishma Rajani et al.
MOLECULAR THERAPY (2016)
Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
Beatriz Vera et al.
PLOS ONE (2016)
Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia
W. Shen et al.
BLOOD (2015)
YVEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection
Rozanne Arulanandam et al.
CANCER CELL (2015)
Ultrasound as a method to enhance antitumor ability of oncolytic herpes simplex virus for head and neck cancer
S. Okunaga et al.
CANCER GENE THERAPY (2015)
Systemic Delivery of an Oncolytic Adenovirus Expressing Decorin for the Treatment of Breast Cancer Bone Metastases
Yuefeng Yang et al.
HUMAN GENE THERAPY (2015)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal Cancer
Se Hoon Park et al.
MOLECULAR THERAPY (2015)
Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses
Norman Woller et al.
MOLECULAR THERAPY (2015)
Encapsulated Stem Cells Loaded With Hyaluronidase-expressing Oncolytic Virus for Brain Tumor Therapy
Jordi Martinez-Quintanilla et al.
MOLECULAR THERAPY (2015)
Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity
Carolina S. Ilkow et al.
NATURE MEDICINE (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Oncolytic viruses: From bench to bedside with a focus on safety
Pascal R. A. Buijs et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression
Roberto Bellucci et al.
ONCOIMMUNOLOGY (2015)
Chimeric antigen receptor-engineered T cells as oncolytic virus carriers
Heather VanSeggelen et al.
MOLECULAR THERAPY-ONCOLYTICS (2015)
Safety Profiles and Antitumor Efficacy of Oncolytic Adenovirus Coated with Bioreducible Polymer in the Treatment of a CAR Negative Tumor Model
Soo-Jung Jung et al.
BIOMACROMOLECULES (2015)
Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction
R. A. Morshed et al.
CANCER GENE THERAPY (2015)
Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression
Alba Rodriguez-Garcia et al.
CLINICAL CANCER RESEARCH (2015)
The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer
W. Xu et al.
GENE THERAPY (2015)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Stem Cells Loaded With Multimechanistic Oncolytic Herpes Simplex Virus Variants for Brain Tumor Therapy
Matthias Duebgen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Switching a Replication-Defective Adenoviral Vector into a Replication-Competent, Oncolytic Adenovirus
Hiroshi Nakashima et al.
JOURNAL OF VIROLOGY (2014)
Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus
Slawomir Antoszczyk et al.
NEURO-ONCOLOGY (2014)
PI3K inhibitor LY294002 inhibits activation of the Akt/mTOR pathway induced by an oncolytic adenovirus expressing TRAIL and sensitizes multiple myeloma cells to the oncolytic virus
Yin Tong et al.
ONCOLOGY REPORTS (2014)
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
Dmitriy Zamarin et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Antibody neutralization of retargeted measles viruses (vol 454, pg 237, 2014)
Patrycja J. Lech et al.
VIROLOGY (2014)
Oncolytic Viruses and Their Application to Cancer Immunotherapy
E. Antonio Chiocca et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Recognition of human oncogenic viruses by host pattern-recognition receptors
Nelson C. Di Paolo
FRONTIERS IN IMMUNOLOGY (2014)
Going viral with cancer immunotherapy
Brian D. Lichty et al.
NATURE REVIEWS CANCER (2014)
Hypoxia and the extracellular matrix: drivers of tumour metastasis
Daniele M. Gilkes et al.
NATURE REVIEWS CANCER (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Macrophage Delivery of an Oncolytic Virus Abolishes Tumor Regrowth and Metastasis after Chemotherapy or Irradiation
Munitta Muthana et al.
CANCER RESEARCH (2013)
Measles Virus Vaccine-Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells
Jean-Baptiste Guillerme et al.
CLINICAL CANCER RESEARCH (2013)
Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus
Anna Kanerva et al.
CLINICAL CANCER RESEARCH (2013)
Manufacturing and banking of mesenchymal stem cells
Sreedhar Thirumala et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma
Qinglei Gao et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Trojan horse at cellular level for tumor gene therapies
Guillaume Collet et al.
GENE (2013)
Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses
K-W Peng et al.
GENE THERAPY (2013)
The role of GM-CSF in enhancing immunotherapy of cancer
Steve H. Thorne
IMMUNOTHERAPY (2013)
Enhanced Tumor Uptake and Penetration of Virotherapy Using Polymer Stealthing and Focused Ultrasound
Robert Carlisle et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Optimizing patient derived mesenchymal stem cells as virus carriers for a Phase I clinical trial in ovarian cancer
Emily K. Mader et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Multimechanistic Tumor Targeted Oncolytic Virus Overcomes Resistance in Brain Tumors
Kaoru Tamura et al.
MOLECULAR THERAPY (2013)
N-acetylcysteine Amide Augments the Therapeutic Effect of Neural Stem Cell-Based Antiglioma Oncolytic Virotherapy
Chung Kwon Kim et al.
MOLECULAR THERAPY (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
Jeong Heo et al.
NATURE MEDICINE (2013)
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma
Omid Hamid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Epitope Dampening Monotypic Measles Virus Hemagglutinin Glycoprotein Results in Resistance to Cocktail of Monoclonal Antibodies
Patrycja J. Lech et al.
PLOS ONE (2013)
Production of Bioactive Soluble Interleukin-15 in Complex with Interleukin-15 Receptor Alpha from a Conditionally-Replicating Oncolytic HSV-1
David C. Gaston et al.
PLOS ONE (2013)
Therapeutic Efficacy and Fate of Bimodal Engineered Stem Cells in Malignant Brain Tumors
Jordi Martinez-Quintanilla et al.
STEM CELLS (2013)
Immunosuppressants Affect Human Neural Stem Cells In Vitro but Not in an In Vivo Model of Spinal Cord Injury
Christopher J. Sontag et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors
Simon Schaefer et al.
BMC CANCER (2012)
Antitumor efficacy of oncolytic herpes simplex virus adsorbed onto antigen-specific lymphocytes
A. Kanzaki et al.
CANCER GENE THERAPY (2012)
Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment
Sebastian Dempe et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
A Novel Therapeutic Regimen to Eradicate Established Solid Tumors with an Effective Induction of Tumor-Specific Immunity
James R. Tysome et al.
CLINICAL CANCER RESEARCH (2012)
Targeted and Armed Oncolytic Poxviruses for Cancer: the Lead Example of JX-594
Caroline J. Breitbach et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Response to Intra-Arterial Oncolytic Virotherapy with the Herpes Virus NV1020 Evaluated by [18F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography
Daniel Y. Sze et al.
HUMAN GENE THERAPY (2012)
Extracellular matrix constituents interfere with Newcastle disease virus spread in solid tissue and diminish its potential oncolytic activity
Barak Yaacov et al.
JOURNAL OF GENERAL VIROLOGY (2012)
A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer
James M. Burke et al.
JOURNAL OF UROLOGY (2012)
A Tumor-stroma Targeted Oncolytic Adenovirus Replicated in Human Ovary Cancer Samples and Inhibited Growth of Disseminated Solid Tumors in Mice
M. Veronica Lopez et al.
MOLECULAR THERAPY (2012)
Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas
Timo M. Kauer et al.
NATURE NEUROSCIENCE (2012)
Therapeutic Effect of Oncolytic Adenovirus Expressing Relaxin in Radioresistant Oral Squamous Cell Carcinoma
Sei Young Lee et al.
ONCOLOGY RESEARCH (2012)
Expression of CCL19 from Oncolytic Vaccinia Enhances Immunotherapeutic Potential while Maintaining Oncolytic Activity
Jun Li et al.
NEOPLASIA (2012)
Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα
I-K Choi et al.
GENE THERAPY (2011)
Rapamycin enhances the activity of oncolytic herpes simplex virus against tumor cells that are resistant to virus replication
Xinping Fu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Neural Stem Cell-based Cell Carriers Enhance Therapeutic Efficacy of an Oncolytic Adenovirus in an Orthotopic Mouse Model of Human Glioblastoma
Atique U. Ahmed et al.
MOLECULAR THERAPY (2011)
A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma
Tae-Ho Hwang et al.
MOLECULAR THERAPY (2011)
Chemokine Expression From Oncolytic Vaccinia Virus Enhances Vaccine Therapies of Cancer
Jun Li et al.
MOLECULAR THERAPY (2011)
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
Caroline J. Breitbach et al.
NATURE (2011)
Assessing oncologic benefit in clinical trials of immunotherapy agents
R. K. Hales et al.
ANNALS OF ONCOLOGY (2010)
Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
Howard L. Kaufman et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer
Evanthia Galanis et al.
CANCER RESEARCH (2010)
Directing systemic oncolytic viral delivery to tumors via carrier cells
Hiroshi Nakashima et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Impact of tumor microenvironment on oncolytic viral therapy
Jeffrey Wojton et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Adipose-derived Stem Cells as Therapeutic Delivery Vehicles of an Oncolytic Virus for Glioblastoma
Darnell T. Josiah et al.
MOLECULAR THERAPY (2010)
Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth
Sonia Guedan et al.
MOLECULAR THERAPY (2010)
Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma
Kah-Whye Peng et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats
A. M. Sonabend et al.
CANCER GENE THERAPY (2009)
Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication
Robin J. Prestwich et al.
CLINICAL CANCER RESEARCH (2009)
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity
E. J. Ilett et al.
GENE THERAPY (2009)
The Influence of Innate and Pre-Existing Immunity on Adenovirus Therapy
Anne K. Zaiss et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
Neil N. Senzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Targeting the Intratumoral Dendritic Cells by the Oncolytic Adenoviral Vaccine Expressing RANTES Elicits Potent Antitumor Immunity
Natalia Lapteva et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy
Candice Willmon et al.
MOLECULAR THERAPY (2009)
Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus
Byram W. Bridle et al.
MOLECULAR THERAPY (2009)
Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response
Anne Gauvrit et al.
CANCER RESEARCH (2008)
Macrophage depletion combined with anticoagulant therapy increases therapeutic window of systemic treatment with oncolytic adenovirus
Elena V. Shashkova et al.
CANCER RESEARCH (2008)
Single-dose, therapeutic vaccination of mice with vesicular stomatitis virus expressing human papillomavirus type 16 E7 protein
John B. Liao et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus
Jian Qiao et al.
CLINICAL CANCER RESEARCH (2008)
The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe
S. Kidd et al.
CYTOTHERAPY (2008)
Syncytia formation affects the yield and cytotoxicity of an adenovirus expressing a fusogenic glycoprotein at a late stage of replication
S. Guedan et al.
GENE THERAPY (2008)
Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial
C. L. White et al.
GENE THERAPY (2008)
Taming the Trojan horse: optimizing dynamic carrier cell/oncolytic virus systems for cancer biotherapy
A. T. Power et al.
GENE THERAPY (2008)
Cell carriers to deliver oncolytic viruses to sites of myeloma tumor growth
A. Munguia et al.
GENE THERAPY (2008)
Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumors
J. Qiao et al.
GENE THERAPY (2008)
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
Byeong-Ho Park et al.
LANCET ONCOLOGY (2008)
Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma
Adam M. Sonabend et al.
STEM CELLS (2008)
Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy
Jian Qiao et al.
NATURE MEDICINE (2008)
A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients
J. Nemunaitis et al.
CANCER GENE THERAPY (2007)
TRAIL in cancer therapy:: present and future challenges
Delphine Merino et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow
Caroline J. Breitbach et al.
MOLECULAR THERAPY (2007)
Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors
Tanja Hakkarainen et al.
HUMAN GENE THERAPY (2007)
Acquired resistance to reoviral oncolysis in Ras-transformed brosarcoma cells
M. Kim et al.
ONCOGENE (2007)
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
Ta-Chiang Liu et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy
Kerry D. Fisher et al.
JOURNAL OF DRUG TARGETING (2007)
A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor
Jennifer C. C. Hu et al.
CLINICAL CANCER RESEARCH (2006)
Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy
Joo-Hang Kim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model
Young-Sook Lee et al.
CLINICAL CANCER RESEARCH (2006)
Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons
SH Ni et al.
HUMAN GENE THERAPY (2005)
Intracarotid delivery of oncolytic HSV vector G47Δ to metastatic breast cancer in the brain
R Liu et al.
GENE THERAPY (2005)
Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors
J García-Castro et al.
CANCER GENE THERAPY (2005)
Patterns of care for adults with newly diagnosed malignant glioma
SM Chang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer
O Ebert et al.
CANCER RESEARCH (2004)
Liposomal enhancement of the antitumor activity of conditionally replication-competent adenoviral plasmids
P Yotnda et al.
MOLECULAR THERAPY (2004)
Gene therapy for matignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein
J Zhang et al.
JOURNAL OF GENE MEDICINE (2004)
Carrier cell-mediated delivery of oncolytic parvoviruses for targeting metastases
Z Raykov et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
DF Stojdl et al.
CANCER CELL (2003)
Acquired resistance to cytolysis of the E1B-attenuated adenovirus, dl1520, in ovarian tumour cell lines
YT Kim et al.
CANCER GENE THERAPY (2003)
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
BL Liu et al.
GENE THERAPY (2003)
Hyaluronidase reduces human breast cancer xenografts in scid mice
S Shuster et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?
D Kirn
GENE THERAPY (2001)
Blood clearance rates of adenovirus type 5 in mice
R Alemany et al.
JOURNAL OF GENERAL VIROLOGY (2000)
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
FR Khuri et al.
NATURE MEDICINE (2000)
Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
M Jo et al.
NATURE MEDICINE (2000)
Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas
U Herrlinger et al.
MOLECULAR THERAPY (2000)
分享论文
